About Phadia
Phadia is a Healthcare company based in Uppsala (Sweden) founded in 1999, and was acquired by Thermo Fisher Scientific in May 2011. Allergy and autoimmune diagnostics solutions are developed using microfluidics. Its chief executive, as recorded, is Magnus Lundberg. Its focus areas include Life Sciences, Immunology, In Vitro Diagnostic Tests and Diversified.
Company details
Phadia was founded in 1999 in Uppsala, Sweden, within the diagnostics sector. Instrumentation for immunoassay diagnostics is specialized in, relying on microfluidics technology. Associated software solutions and assays are created to integrate with these systems, supporting clinical applications in allergy and autoimmune testing across healthcare settings.
- Headquarters Uppsala, Sweden
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website phadia.com
- Social LinkedIn
- Acquired by Thermo Fisher Scientific (May 2011)
- InvestorsThermo Fisher Scientific
& 2 more
- Acquired by
Funding Insights of Phadia
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Phadia with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2007 | Debt – Conventional | – | – |
3 investors in total: 3 institutional.
Investors in Phadia
Phadia has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Thermo Fisher Scientific, Ardian and Cinven.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private investment firm specializing in markets and partnerships. | ardian.com | |||
Private equity investments and portfolio management services are provided by Cinven across various sectors. | cinven.com | |||
Electron microscopy services and microanalysis instruments are provided. | 1956 | thermofisher.com | Waltham, United States |
Investor details for Phadia
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Phadia
1 people are tracked at Phadia (1 in leadership).
| Name | Role | Group |
|---|---|---|
Magnus Lundberg | CEO | Leadership |
Complete people profiles for Phadia
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Phadia
4 dated milestones of Phadia across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Phadia is founded.
- Exit Acquired by Cinven.
- Funding First funding round.
- Exit Acquired by Thermo Fisher Scientific.
Web traffic of Phadia
The website of Phadia (phadia.com) receives about 5.1K visits a month and ranks #3,952,566 among all websites worldwide, #4,989 in Biotechnology and Pharmaceuticals.
- Monthly visits5.1K
▲ 23.5% vs previous month
- Unique visitors2K
per month
- Global rank#3,952,566
among all websites
- Category rank#4,989
Health · Biotechnology and Pharmaceuticals
- Bounce rate40%
- Pages per visit2.2
- Average visit1 min 00 sec
- DevicesDesktop 29% · Mobile 71%
Websites whose visitors overlap most with Phadia. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| remel.com | 100% | 5.6K | View details | ||
| patheon.com | 81% | 89.1K | #488,648 | View details | |
| allos.com | 81% | View details | |||
| ipsen.com | 81% | 112.9K | #336,868 | View details | |
| impaxlabs.com | 81% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 25 similar websites and full traffic analytics for Phadia
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 25 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Phadia
Phadia was founded in 1999 and raised its 1st funding round 8 years after it was founded.
Phadia is headquartered in Uppsala, Sweden. It is registered at Uppsala, Uppsala County, Sweden.
Magnus Lundberg is the CEO of Phadia, as recorded in our data.
Phadia was founded in 1999 in Uppsala, Sweden, within the diagnostics sector. Instrumentation for immunoassay diagnostics is specialized in, relying on microfluidics technology. Associated software solutions and assays are created to integrate with these systems, supporting clinical applications in allergy and autoimmune testing across healthcare settings.
Phadia has 3 investors. Key investors include Thermo Fisher Scientific, Ardian, and Cinven.
Yes. Phadia was acquired by Thermo Fisher Scientific in May 2011.